Tharimmune Inc Sustainability Reports
The company operates clinical-stage biotechnology research and development alongside developing institutional digital asset strategies and treasury functions supporting blockchain ecosystem infrastructure.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 52990040X8C60JYNXZ70
No reports are currently available in our catalogue.